LAUREN P SILVERNAIL Insider Trading $ISTA ISTA PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LAUREN P SILVERNAIL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LAUREN P SILVERNAIL. LAUREN P SILVERNAIL is CFO in ISTA PHARMACEUTICALS INC ($ISTA) and Chief Financial Officer in ISTA PHARMACEUTICALS INC ($ISTA).
LAUREN P SILVERNAIL in ISTA PHARMACEUTICALS INC
Trading Symbol: ISTAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LAUREN P SILVERNAIL: CFO, Chief Financial Officer
Holdings: 185,020 shares
Latest Transaction: May 10 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of LAUREN P SILVERNAIL in ISTA PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Option Exercise | M | 7.43 | 13,717 | 101,917 | 0 | |
May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Option Exercise | M | 6.82 | 2,212 | 15,086 | 25,542 | |
May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Option Exercise | M | 6.77 | 17,203 | 116,464 | 0 | |
May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Option Exercise | M | 5.40 | 65,867 | 355,682 | 0 | |
May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Option Exercise | M | 4.46 | 18,903 | 84,307 | 0 | |
May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Option Exercise | M | 3.63 | 11,262 | 40,881 | 20,564 | |
May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Option Exercise | M | 1.04 | 16,649 | 17,315 | 8,814 | |
May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Payment of Exercise | F | 9.08 | 1,661 | 15,082 | 185,020 | 186.7 K to 185 K (-0.89 %) |
May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Buy | M | 6.82 | 2,212 | 15,086 | 186,681 | 184.5 K to 186.7 K (+1.20 %) |
May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Payment of Exercise | F | 9.08 | 4,502 | 40,878 | 184,469 | 189 K to 184.5 K (-2.38 %) |
May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Buy | M | 3.63 | 11,262 | 40,881 | 188,971 | 177.7 K to 189 K (+6.34 %) |
May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Payment of Exercise | F | 9.08 | 1,907 | 17,316 | 177,709 | 179.6 K to 177.7 K (-1.06 %) |
May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Buy | M | 1.04 | 16,649 | 17,315 | 179,616 | 163 K to 179.6 K (+10.22 %) |
May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Payment of Exercise | F | 9.08 | 11,224 | 101,914 | 162,967 | 174.2 K to 163 K (-6.44 %) |
May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Buy | M | 7.43 | 13,717 | 101,917 | 174,191 | 160.5 K to 174.2 K (+8.55 %) |
May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Payment of Exercise | F | 9.08 | 12,826 | 116,460 | 160,474 | 173.3 K to 160.5 K (-7.40 %) |
May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Buy | M | 6.77 | 17,203 | 116,464 | 173,300 | 156.1 K to 173.3 K (+11.02 %) |
May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Payment of Exercise | F | 9.08 | 39,172 | 355,682 | 156,097 | 195.3 K to 156.1 K (-20.06 %) |
May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Buy | M | 5.40 | 65,867 | 355,682 | 195,269 | 129.4 K to 195.3 K (+50.90 %) |
May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Payment of Exercise | F | 9.08 | 9,285 | 84,308 | 129,402 | 138.7 K to 129.4 K (-6.69 %) |
May 10 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Buy | M | 4.46 | 18,903 | 84,307 | 138,687 | 119.8 K to 138.7 K (+15.78 %) |
Feb 09 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Sell | D | 8.15 | 1,066 | 8,688 | 119,784 | 120.9 K to 119.8 K (-0.88 %) |
Feb 09 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Sell | D | 8.17 | 1,146 | 9,363 | 120,850 | 122 K to 120.9 K (-0.94 %) |
Feb 06 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Sell | D | 8.22 | 942 | 7,743 | 121,996 | 122.9 K to 122 K (-0.77 %) |
Feb 06 2012 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Sell | D | 8.18 | 942 | 7,706 | 122,938 | 123.9 K to 122.9 K (-0.76 %) |
Dec 02 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Option Exercise | A | 3.75 | 122,875 | 460,781 | 122,875 | |
Dec 02 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Grant | A | 0.00 | 27,375 | 27 | 123,880 | 96.5 K to 123.9 K (+28.37 %) |
Aug 15 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Buy | P | 4.30 | 30 | 129 | 96,505 | 96.5 K to 96.5 K (+0.03 %) |
Aug 15 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Buy | P | 4.29 | 400 | 1,716 | 96,475 | 96.1 K to 96.5 K (+0.42 %) |
Aug 15 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Buy | P | 4.28 | 2,070 | 8,860 | 96,075 | 94 K to 96.1 K (+2.20 %) |
May 12 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Option Exercise | M | 4.46 | 29,097 | 129,773 | 0 | |
May 12 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Option Exercise | M | 3.63 | 12,033 | 43,680 | 3,141 | |
May 12 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Option Exercise | M | 1.04 | 21,537 | 22,398 | 0 | |
May 12 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Payment of Exercise | F | 11.26 | 6,870 | 77,356 | 94,005 | 100.9 K to 94 K (-6.81 %) |
May 12 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Buy | M | 3.63 | 12,033 | 43,680 | 100,875 | 88.8 K to 100.9 K (+13.54 %) |
May 12 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Payment of Exercise | F | 11.26 | 9,159 | 103,130 | 88,842 | 98 K to 88.8 K (-9.35 %) |
May 12 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Buy | M | 1.04 | 21,537 | 22,398 | 98,001 | 76.5 K to 98 K (+28.17 %) |
May 12 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Payment of Exercise | F | 11.26 | 17,971 | 202,353 | 76,464 | 94.4 K to 76.5 K (-19.03 %) |
May 12 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Buy | M | 4.46 | 29,097 | 129,773 | 94,435 | 65.3 K to 94.4 K (+44.53 %) |
Feb 10 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Sell | D | 7.48 | 1,104 | 8,258 | 65,338 | 66.4 K to 65.3 K (-1.66 %) |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Option Exercise | A | 6.82 | 21,396 | 145,921 | 21,396 | |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Option Exercise | A | 6.82 | 27,754 | 189,282 | 27,754 | |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Grant | A | 0.00 | 10,950 | 11 | 66,442 | 55.5 K to 66.4 K (+19.73 %) |
Feb 07 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Sell | D | 6.15 | 736 | 4,526 | 56,438 | 57.2 K to 56.4 K (-1.29 %) |
Feb 07 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Sell | D | 6.15 | 946 | 5,818 | 57,174 | 58.1 K to 57.2 K (-1.63 %) |
Feb 07 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Sell | D | 6.20 | 946 | 5,865 | 55,492 | 56.4 K to 55.5 K (-1.68 %) |
Page: 1